| data suggest that miR-193b is an epigenetically silenced putative tumor suppressor in prostate cancer | prostate, |
| study found that miR-193b was down-regulated in non-small cell lung cancer (NSCLC), and that miR-193b inhibited NSCLC cancer cell proliferation and invasion in vitro; data suggest that miR-193b is a tumor suppressor in NSCLC | lung, |
| MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia. | leukemia, |
| Re-expression of miR-193b in breast cancer cell lines decreased DNAJC13 (HPS40) and RAB22A expression, providing a mechanism by which mir193-b acts as a tumor suppressor. | breast, |
| Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia | leukemia, |
| MicroRNA-193b acts as a tumor suppressor gene in human esophageal squamous cell carcinoma via target regulation of KRAS | esophageal, |
| MicroRNA-193b acts as a tumor suppressor in colon cancer progression via targeting RAB22A | colorectal, |
| Dual-strand tumor suppressor miR-193b-3p and -5p inhibit malignant phenotypes of lung cancer by suppressing their common targets. | lung, |